Showing results (1701-1710 of 1,837) with videos related to
Sort By:
Pageof 184
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.Research Square|January 10, 2024
Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)Kathryn E Hitchcock, Eric D Miller, Qian Shi, et al.BMC Cancer|February 13, 2024
Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)Kathryn E Hitchcock, Eric D Miller, Qian Shi, et al.Annals of the American Thoracic Society|October 24, 2024
Low Lung Function Is Associated with High Population Attributable Fraction for Cardiovascular MortalitySurya P Bhatt, Chaoqi Wu, Yifei Sun, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.Transplantation|November 1, 2017
Brain Integrity Changes Underlying Cognitive and Functional Recovery Postliver Transplant Continue to Evolve Over 1 YearVishwadeep Ahluwalia, James B Wade, Melanie B White, et al.JAMA|April 20, 2026
Using Serious Games to Increase the Implementation of Trauma Triage Guidelines: A Randomized Clinical TrialDeepika Mohan, Chung-Chou H Chang, Baruch Fischhoff, et al.European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversionFaiez Zannad, Wendy Gattis Stough, Raymond J Lipicky, et al.American Journal of Respiratory and Critical Care Medicine|May 16, 2015
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care UnitsGabriel T Bosslet, Thaddeus M Pope, Gordon D Rubenfeld, et al.Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.Pageof 184